4528.T
ONO PHARMACEUTICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 2,490.00
+0.81%Year over year
Reported trailing growth
- Revenue
- +4.5%
- EBITDA
- —
- EBIT
- -10.2%
- EPS
- -15.3%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -3.8%
- EBITDA
- —
- EPS
- +7.4%
Three-year CAGR
- Revenue
- +10.4%
- EBITDA
- -10.5%
- EBIT
- -16.7%
- Net income
- -14.7%
- EPS
- -13.1%
- Free cash flow
- +11.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026